Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2007
11/22/2007US20070269429 Treatment with anti-erbb2 antibodies
11/22/2007US20070269403 Composition and method for treatment of hepatic encephalopathy
11/22/2007CA2652500A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007CA2652499A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007CA2652333A1 Pharmaceutical composition for treating or preventing hcv infection
11/22/2007CA2652041A1 Food compositions and methods of treating periodontal disease
11/22/2007CA2652023A1 New form of administration of racecadotril
11/22/2007CA2651883A1 Method and means for treating inflammatory bowel disease
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007EP1857546A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/21/2007EP1857459A2 Pyrazolopyrimidine compound and a process for preparing the same
11/21/2007EP1857445A2 Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1857105A2 Cathartic composition
11/21/2007EP1856153A1 Ykl-40 monoclonal antibodies
11/21/2007EP1856146A2 Fgf growth factor analogs
11/21/2007EP1856110A1 Oxyindole derivatives as 5ht4 receptor agonists
11/21/2007EP1856067A1 Crystal forms of 2-(3-fluoro4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators
11/21/2007EP1856041A1 Crystallisation and purification of glycopyrronium bromide
11/21/2007EP1855681A1 Method of treatment of diarrhea-predominant irritable bowel syndrome in a subject
11/21/2007EP1855680A2 Method of treatment of diarrhea-predominant ibs in a female subject receiving contraceptive therapy
11/21/2007EP1855550A2 Nutritional composition with probiotics
11/21/2007EP1505964B1 Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
11/21/2007EP1474140B1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1350112B1 Methods for the treatment of ibs
11/21/2007EP1315485B1 Cathartic composition
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007EP1188445B1 Drug composition containing lecithin-modified superoxide dismutase
11/21/2007EP0981374B1 Sustained-release delayed gels
11/21/2007EP0842196B1 Cell adhesion inhibitors
11/21/2007CN101076542A Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof
11/21/2007CN101076521A Process for producing muscarine receptor antagonist and intermediate therefor
11/21/2007CN101076350A Compositions for hcv treatment
11/21/2007CN101076346A Lactic acid bacteria and its application in preventing diarrhea
11/21/2007CN101076329A Methods for purifying trans-(-)-delta;9-tetrahydrocannabinol and trans-(+)-delta;9-tetrahydrocannabinol
11/21/2007CN101074415A Acanthopanax-root wine and its production
11/21/2007CN101074228A Method for preparing medicine composition containing 1,3-oxathin cyclopentane nucleoside analogues
11/21/2007CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007CN101074202A Production of injecting reductive glutathione
11/21/2007CN101073685A Medicinal-magnetic seat cushion and back cushion
11/21/2007CN101073660A Chinese-medicinal composition for treating chronic hepatitis B and its production
11/21/2007CN101073657A 'Yu Chuang Dan' Chinese-medicinal preparation for treating recurrent oral exulceratio
11/21/2007CN101073648A Method for treating senile constipation
11/21/2007CN101073645A Body-building oral liquid
11/21/2007CN101073617A Use of medicinal composition in treatment of micro-circulation handicap and prevention of stroke
11/21/2007CN101073609A Fuming cirrus for treating hepatitis B, its production and use
11/21/2007CN101073605A Bistort Rhizome effective component and its use
11/21/2007CN101073602A Medicinal composition for treating or improving liver function, its production and use
11/21/2007CN101073601A Chinese medicine for treating acute enteronitis and its disperse tablet
11/21/2007CN101073595A Glycyrrhiza total flavonoid and total saponin extract and its production
11/21/2007CN101073593A Compound bi-dismutation agent and its production
11/21/2007CN101073590A Muxiang total lactone extract and its production
11/21/2007CN101073585A Microbial preparation for improving eel liver growth and its making method
11/21/2007CN101073576A Aldoforwe ester self-emulsifying capsule preparation and its making method
11/21/2007CN101073427A Glossy ganoderma cordycepin beverage and its production
11/21/2007CN101073407A Edible refreshing pearl and its production
11/21/2007CN101073358A Intestines-nourishing tea
11/21/2007CN101073356A Stomach-invigorating and bowel-relaxing tea
11/21/2007CN101073351A Memory-enhancing tea with brain-invigorating and vision-improving functions
11/21/2007CN101073350A White Chinese herbaceous peony tea with bowel-relaxing function
11/21/2007CN101073340A Rose beauty sour milk
11/21/2007CN101073333A Multi-flavor biscuit
11/21/2007CN101073330A Appetizing Baxian cake
11/21/2007CN100349922C Nanometer mushroom amylose and preparation method of its injection
11/21/2007CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2007CN100349613C Botulinum toxin oral formulation and use thereof for treating peptic ulcers and gastroesophageal reflux disease
11/21/2007CN100349610C Oral adhering piece for treating oral exulceratio, and its prepn. method
11/21/2007CN100349609C Cirrhosis treating medicine
11/21/2007CN100349607C Extraction and purification of Chinese medicine for treating ulcer colonitis and clinical research
11/21/2007CN100349599C Swim bladder marrow growing capsule
11/21/2007CN100349595C Medicinal composition for catharsis
11/21/2007CN100349587C Medicine for treating acute and chronic pancreatitis
11/21/2007CN100349580C Mould catching agent and medicinal/health caring use
11/21/2007CN100349578C Medicine composition for treating atrophic gastritis
11/21/2007CN100349574C Drugs for periodontal diseases
11/21/2007CN100349567C (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application
11/21/2007CN100349524C Combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297715 PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297682 liquid crystal diphosphate polymorph; antibacterial and antiprotozoal agents
11/20/2007US7297523 Human elongase genes and uses thereof
11/20/2007US7297346 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain attention deficit hyperactivity disorder and fatigue
11/20/2007US7297332 Protease, a gene therefor and the use thereof
11/15/2007WO2007130823A2 Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor
11/15/2007WO2007129963A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129962A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129961A1 Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
11/15/2007WO2007129743A1 Anti-inflammatory composition
11/15/2007WO2007129725A1 Agent for preventing liver disease
11/15/2007WO2007129701A1 Method of producing dry yeast containing s-adenosyl-l-methionine and composition for oral intake
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129428A1 Method for isolation of stem cell
11/15/2007WO2007129040A1 p38 MAP KINASE INHIBITORS
11/15/2007WO2007128462A1 Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms